Published in Vaccine Weekly, February 12th, 2003
"The occurrence of systemic anaphylactic side-effects in the course of allergen-specific immunotherapy has been strongly reduced by the adsorption of allergens to aluminum hydroxide, the most frequently used adjuvant in humans," said Hans Gronlund and colleagues at the Karolinska Institutet in Stockholm, Sweden, and the University of Vienna in Austria. "Using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly